Anti-Fibrotic Drug Development Summit (AFDD) Boston, Massachusetts, USA 13-14 November 2017

Description:
This Anti-Fibrotic Drug Development conference will be a unique opportunity for drug developers focused on organ-specific indications to participate in a cross-disciplinary, multi-organ discussions in order to gain new insights into their anti-fibrotic drug development research.

Attending this comprehensive forum will enable you to; identify which fibrotic mechanisms are driving pathology changes in humans; effectively translate from preclinical to clinical development and robustly select patient populations.

URLs:
Brochure: https://go.evvnt.com/147139-1
Booking: https://go.evvnt.com/147139-2

Prices:
Register by August 18 to save $300: USD 2399,
Register by September 8 to save $200: USD 2499,
Register by October 6 to save $100: USD 2599,
Standard Rate: USD 2699.

Speakers: Ray Jupp (UCB), Richard Marshall (GSK), Lisa Hazelwood (AbbVie), Peter Blume-Jensen (Xtuit Pharmaceuticals), Alexey Lugovskoy (Morphic Therapeutics), Seth Porter (FibroGen)

Time: 8:20 am to 3:45 pm.